Potentially dangerous misuse of the Hartford once-daily nomogram for gentamicin

Journal of Antimicrobial Chemotherapy

Volumn 64, Issue 5, 2009, Pages 1117-1118

  Lovering, A M ^a   Reeves, D S ^a  

^a NORTH BRISTOL NHS TRUST   (United Kingdom)

Author keywords

Aminoglycosides; Prescribing practice; Therapeutic drug monitoring

Indexed keywords

GENTAMICIN; ANTIINFECTIVE AGENT;

DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG USE; HUMAN; KIDNEY FUNCTION; LETTER; NOMOGRAM; UNITED KINGDOM; BACTERIAL INFECTION; CHEMISTRY; SERUM; TIME;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; GENTAMICINS; GREAT BRITAIN; HUMANS; NOMOGRAMS; SERUM; TIME FACTORS;

EID: 73949147038     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkp323     Document Type: Letter

References (3)

1. Freeman CD, Nicolau DP, Belliveau PP et al. Once-daily dosing of aminoglycosides: review and recommendations for clinical practice. J Antimicrob Chemother 1997; 39: 677-86.
2. Nicolau DP, Freeman CD, Belliveau PP et al. Experience with a once-daily aminoglycoside program administered to 2,184 adult patients. Antimicrob Agents Chemother 1995; 39: 650-5.
3. Urban AW, Craig WA. Daily dosage of aminoglycosides. In: Remington JS, Swartz MN, eds. Current Clinical Topics in Infectious Diseases, Volume 17. Malden, MA: Blackwell Science, 1997; 236-55.